Resources

Selected
  • Systematic reviews (SYSVAC)
Type of publications
Regions
Diseases
Vaccine topics
Target population
Publication date

3220 results found

2023 ∙ Fu, Y. Zhao, J. Han, P. Zhang, J. Wang, Q. Wang, Q. Wei, X. Yang, L. Ren, T. Zhan, S. Li, L.

Cost-effectiveness of COVID-19 vaccination: A systematic review

  • All age groups
  • COVID-19
  • Economic aspects
Methodological quality (AMSTAR 2):
Not applicable
2023 ∙ Getchell, M. Mantaring, E. J. Yee, K. Pronyk, P.

Cost-effectiveness of sub-national geographically targeted vaccination programs: A systematic review

  • Newborn
  • Children
  • Adolescents
  • Economic aspects
Methodological quality (AMSTAR 2):
Not applicable
2023 ∙ Giannelos, Nikolaos Ng, Cheryl Curran, Desmond

Cost-effectiveness of the recombinant zoster vaccine (RZV) against herpes zoster: An updated critical review

  • Adults
  • Older adults
  • Herpes zoster
  • Economic aspects
Methodological quality (AMSTAR 2):
Not applicable
2023 ∙ Lo Moro, G. Ferrara, M. Langiano, E. Accortanzo, D. Cappelletti, T. De Angelis, A. Esposito, M. Prinzivalli, A. Sannella, A. Sbaragli, S. Vuolanto, P. Siliquini, R. De Vito, E.

Countering vaccine hesitancy: a systematic review of interventions to strengthen healthcare professionals' action

  • Healthcare workers
  • Acceptance
  • Ethical issues
Methodological quality (AMSTAR 2):
Not applicable
2023 ∙ Sidhu, N. Vanathi, M. Gupta, N. Tandon, R.

COVID and COVID vaccine-related corneal morbidity: A review

  • Adults
  • Older adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Agustin, M. Trifitriana, M. Danarti, R.

COVID arm as a common cutaneous manifestation after mRNA-1273 vaccination: a systematic review

  • All age groups
  • COVID-19
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Bianchi, F. P. Donghia, R. Tatoli, R. Bonfiglio, C.

COVID-19 Immunization Rates in Patients with Inflammatory Bowel Disease Worldwide: A Systematic Review and Meta-Analysis

  • Adults
  • COVID-19
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2023 ∙ Al Kadri, H. M. Al Sudairy, A. A. Alangari, A. S. Al Khateeb, B. F. El-Metwally, A. A.

COVID-19 vaccination and menstrual disorders among women: Findings from a meta-analysis study

  • All age groups
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Kontovazainitis, C. G. Katsaras, G. N. Gialamprinou, D. Mitsiakos, G.

Covid-19 vaccination and pregnancy: a systematic review of maternal and neonatal outcomes

  • Pregnant women
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
High
2023 ∙ Shafiee, A. Kohandel Gargari, O. Teymouri Athar, M. M. Fathi, H. Ghaemi, M. Mozhgani, S. H.

COVID-19 vaccination during pregnancy: a systematic review and meta-analysis

  • Pregnant women
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Low
Loading...